戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                        Thirty patients had a benign nodule.
2 alignant non-calcified nodules and one had a benign nodule.
3         No participant had thoracotomy for a benign nodule.
4 ents, it was ultimately proven that they had benign nodules.
5 ncreased their detection of lung cancers and benign nodules.
6 nditions, including histologically diagnosed benign nodules.
7 ign and malignant nodules; 17 (42%) had only benign nodules.
8 differentiating small malignant nodules from benign nodules.
9 optimal discrimination between malignant and benign nodules.
10 lignant, three high-grade dysplastic, and 20 benign nodules.
11 e TSHR variants detected, (6/7, 86%) were in benign nodules.
12  1.00) for differentiation of malignant from benign nodules.
13 limation), which included 59 cancers and 163 benign nodules (3-20 mm).
14 t data were available for 4431 nodules (4315 benign nodules and 116 malignant nodules) from the NLST
15 images to that on 80-kVp images was 2 HU for benign nodules and 3 HU for malignant nodules.
16 ressed in thyroid malignancies compared with benign nodules and normal thyroid tissues.
17                             The frequency of benign nodules and the inconsistency of predictions base
18 odules), the specificity was 58% (107 of 185 benign nodules), and the accuracy was 77% (274 of 356 no
19                  Patients with cytologically benign nodules are best followed without thyroxine treat
20                            A large number of benign nodules are reported among smokers in lung cancer
21                      Seventy-seven of 87 had benign nodules because of resolution or 2-year stability
22                                  The rate of benign nodule detection is high.
23                                  The rate of benign nodule detection is high.
24                                              Benign nodule detection rate is high.
25 necessary tests and surgery in patients with benign nodules, especially those who have limited life e
26 ltiple thresholds were tested to distinguish benign nodules from malignant nodules.
27                                    All eight benign nodules had doubling times of 396 days or greater
28       However, in addition to a high rate of benign nodules, lung cancer screening detects a large nu
29 557), and lung cancer patients (n=30) versus benign nodules (n=128).
30 sion (negative screening result); calcified, benign nodule (negative screening result); or no nodule
31 (SD 0.67) in malignant and 1.02 (SD 0.06) in benign nodules (P = 0.0099).
32                                         Most benign nodules remain stable in size and remain benign w
33  the finding that variants are also found in benign nodules, testing only GEC suspicious nodules may
34                                  The risk of benign nodules was elevated in women (relative risk (RR)
35 adiographs of 34 primary lung cancers and 22 benign nodules were digitized with a 0.175-mm pixel size
36                                        Seven benign nodules were resected.
37 that depicted 31 primary lung cancers and 22 benign nodules were used.
38 emma is to distinguish between a more common benign nodule, which usually does not require specific t
39 Thin-section CT findings of malignant versus benign nodules with pure GGO (17 vs 12 lesions), mixed G

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。